An $8 Million Glimpse Into the Conflict-of-Interest World at California's Cell and Gene Therapy Enterprise
A mea culpa letter, secrecy and "blinded" decisions
Editor’s note: An earlier, slightly different version of this article first appeared this morning on Capitol Weekly, the respected state government news and information service.
Call it “The Case of the Killer Cells.” It is an $8 million matter involving an effort by California’s ambitious s…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.